OMX Copenhagen 20
2.095,60
PKT
+75,49
PKT
+3,74
%
Werbung
Analysen zu OMX Copenhagen 20-Werten
Datum | Rating | Analyst | |
---|---|---|---|
22.01.20 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
20.01.20 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
17.01.20 | Novo Nordisk overweight | Barclays Capital | |
17.01.20 | Novo Nordisk Neutral | UBS AG | |
17.01.20 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
16.01.20 | Novo Nordisk overweight | Barclays Capital | |
16.01.20 | Novo Nordisk Outperform | Credit Suisse Group | |
06.01.20 | Novo Nordisk neutral | Morgan Stanley | |
06.01.20 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
06.01.20 | Novo Nordisk kaufen | Bernstein Research | |
20.12.19 | A.P. Moeller - Maersk A-S (B) buy | Jefferies & Company Inc. | |
19.12.19 | A.P. Moeller - Maersk A-S (B) Neutral | Goldman Sachs Group Inc. | |
17.12.19 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
12.12.19 | Novo Nordisk Hold | Deutsche Bank AG | |
06.12.19 | Novo Nordisk Neutral | UBS AG | |
28.11.19 | A.P. Moeller - Maersk A-S (B) Underweight | JP Morgan Chase & Co. | |
27.11.19 | Novo Nordisk Reduce | HSBC | |
25.11.19 | A.P. Moeller - Maersk A-S (B) buy | Kepler Cheuvreux | |
22.11.19 | A.P. Moeller - Maersk A-S (B) Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
21.11.19 | Novo Nordisk Hold | Deutsche Bank AG | |
21.11.19 | Novo Nordisk Neutral | UBS AG | |
21.11.19 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
21.11.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
19.11.19 | A.P. Moeller - Maersk A-S (B) verkaufen | Barclays Capital | |
18.11.19 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
18.11.19 | A.P. Moeller - Maersk A-S (B) Outperform | Credit Suisse Group | |
18.11.19 | Novo Nordisk Neutral | UBS AG | |
18.11.19 | Novo Nordisk overweight | Barclays Capital | |
15.11.19 | A.P. Moeller - Maersk A-S (B) Neutral | Goldman Sachs Group Inc. | |
11.11.19 | Novo Nordisk Hold | Deutsche Bank AG | |
06.11.19 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
04.11.19 | Novo Nordisk Outperform | Credit Suisse Group | |
04.11.19 | Novo Nordisk Equal weight | Barclays Capital | |
04.11.19 | Novo Nordisk Hold | Deutsche Bank AG | |
04.11.19 | Novo Nordisk Outperform | Bernstein Research | |
04.11.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
01.11.19 | Novo Nordisk Equal weight | Barclays Capital | |
01.11.19 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
01.11.19 | Novo Nordisk buy | UBS AG | |
01.11.19 | Novo Nordisk overweight | JP Morgan Chase & Co. |